The neuroimmune modulation therapy system is designed for individuals with moderate-to-severe rheumatoid arthritis. Credit: Chinnapong / Shutterstock.com. · Medical Device Network · Chinnapong / ...
SetPoint Medical, a commercial-stage medical technology company dedicated to improving care for people living with chronic ...
VALENCIA, Calif.--(BUSINESS WIRE)--SetPoint Medical, a biomedical technology company developing neuromodulation therapies for inflammatory diseases, announced today that it has secured $27 million in ...
VALENCIA, Calif.–(BUSINESS WIRE)–SetPoint Medical, a clinical-stage biomedical technology company developing a bioelectronic therapy for chronic inflammatory diseases, announced today the appointment ...
VALENCIA, Calif., May 4, 2026 /PRNewswire/ -- SetPoint Medical, a medical technology company dedicated to improving care for people living with chronic autoimmune diseases, today announced that ...
VALENCIA, Calif.--(BUSINESS WIRE)-- SetPoint Medical, a clinical-stage healthcare company dedicated to patients with chronic autoimmune diseases, today announced a senior secured term loan facility of ...
VALENCIA, Calif., Sept. 10, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage company developing therapy for chronic autoimmune diseases, today announced the appointment of Anna Gawlicka, ...
PENSACOLA, FL, UNITED STATES, April 22, 2026 /EINPresswire.com/ — Lovell ® Government Services and SetPoint Medical, a commercial-stage medical technology company ...
VALENCIA, Calif.--(BUSINESS WIRE)--SetPoint Medical, a clinical-stage company developing bioelectronic therapy for chronic inflammatory diseases, announced today the appointment of Murthy Simhambhatla ...
SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced positive long-term data for its first-in-human study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results